An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (Natrox™) on the Rates of

Healing of Chronic Diabetic Foot Ulcers (OTONAL Trial)
Natrox™ topical oxygen therapy (TOT) (Inotec AMD Ltd, Hertfordshire, UK) employs a small battery-powered “oxygen generator” to concentrate atmospheric oxygen and feeds pure, moist, oxygen through a fine, soft tube to a dressing-like “oxygen distribution system”, which is placed over the wound and is held in place by a conventional dressing. The aim was to determine the effectiveness of Natrox™ for non-healing diabetic foot ulcers (DFU) over a 3-month period.Longitudinal, single-arm, open prospective registry study using 12 weeks of TOT using a 4 week run-in period. 20 patients recruited to OTONAL had chronic DFU greater than 3 months duration or minor amputation sites with less than 50% healing in 4 weeks.There were 13 (65%) males and the mean age was 65.7 (±11.6) years. The mean glycated haemoglobin (HbA1c) was 6.9 (±1.3) mmol mol-1 and mean wound duration before TOT was 114 (±79.1) days. 18/20 (90.0%) patients had concomitant lower limb revascularization angioplasty for chronic limb threatening ischaemia. The mean size … read more

AmnioText from Regenative Labs

AmnioText™ patches are produced from human amniotic membranes and can be placed on the wound closure sites after a medical procedure or directly onto an open wound. The allografts are minimally manipulated and undergo an extensive and comprehensive testing process. The patches are produced in our first-class, state-of-the-art lab in Pensacola, Florida, to ensure the highest quality tissue allografts available. Click here to request more information